Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Summary Keywords glucagon-like peptide-1 receptor, Alzheimers disease, diabetes mellitus, insulin resistance, neuroinflammation Citation Li S, Huang N, Wang M, Huang W, Shi J, Luo Y and Huang J (2025) GLP-1R as a potential link between diabetes and Alzheimers disease
22 EkayantiMSauriasariRElyaB
Additionally, NCOA4-ferritin heavy polypeptide 1-mediated iron metabolism disorder is related to retinal ganglion cell ferroptosis following pathologically high intraocular pressure injury [37]
Yadav UC, Ramana KV, Aguilera-Aguirre L, Boldogh I, Boulares HA, Srivastava SK
2D) as reported previously 25
In January, Novo struck new partnerships with Cellarity and Omega Therapeutics to develop new cardiometabolic drugs, just six months after Lillys July 2023 acquisition of Versanis and its lead asset bimagrumab, a monoclonal antibody that aims to reduce fat without affecting muscle mass
00002-4/asset/ee009d40-8568-4a1e-af0e-c7832a10baec/main.assets/gr1_lrg.jpg)
US$ 26.27
US$ 28.69
US$ 28.46
US$ 28.90
US$ 27.13
US$ 29.64
US$ 22.51
